Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Operating Leases (2023 - 2025)

Historic Operating Leases for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $3.0 million.

  • Nuvation Bio's Operating Leases rose 20152.28% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 20152.28%. This contributed to the annual value of $969000.0 for FY2024, which is 5238.33% down from last year.
  • Per Nuvation Bio's latest filing, its Operating Leases stood at $3.0 million for Q3 2025, which was up 20152.28% from $3.4 million recorded in Q2 2025.
  • Nuvation Bio's Operating Leases' 5-year high stood at $3.8 million during Q1 2025, with a 5-year trough of $969000.0 in Q4 2024.
  • For the 3-year period, Nuvation Bio's Operating Leases averaged around $2.2 million, with its median value being $2.4 million (2023).
  • Its Operating Leases has fluctuated over the past 5 years, first plummeted by 6135.74% in 2024, then skyrocketed by 24969.14% in 2025.
  • Over the past 3 years, Nuvation Bio's Operating Leases (Quarter) stood at $2.0 million in 2023, then crashed by 52.38% to $969000.0 in 2024, then soared by 206.5% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $3.4 million for Q2 2025, and $3.8 million during Q1 2025.